nimodipine has been researched along with Epilepsy, Absence in 3 studies
Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.
Epilepsy, Absence: A seizure disorder usually occurring in childhood characterized by rhythmic electrical brain discharges of generalized onset. Clinical features include a sudden cessation of ongoing activity usually without loss of postural tone. Rhythmic blinking of the eyelids or lip smacking frequently accompanies the SEIZURES. The usual duration is 5-10 seconds, and multiple episodes may occur daily. Juvenile absence epilepsy is characterized by the juvenile onset of absence seizures and an increased incidence of myoclonus and tonic-clonic seizures. (Menkes, Textbook of Child Neurology, 5th ed, p736)
| Excerpt | Relevance | Reference |
|---|---|---|
| "ethosuximide, an increase after i." | 1.31 | Opposite effects of T- and L-type Ca(2+) channels blockers in generalized absence epilepsy. ( Elants, C; Scheenen, W; van Luijtelaar, G; Wiaderna, D, 2000) |
| "Although calcium antagonists possess antiepileptic properties in various models of epilepsy, their role after chronic administration and in models for generalized absence epilepsy has not been studied." | 1.29 | The effects of chronic treatment with a calcium channel antagonist on two types of generalized epilepsies in rats. ( Ates, N; van der Staay, FJ; van Luijtelaar, EL, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| van Luijtelaar, EL | 2 |
| Ates, N | 2 |
| Coenen, AM | 1 |
| van der Staay, FJ | 1 |
| van Luijtelaar, G | 1 |
| Wiaderna, D | 1 |
| Elants, C | 1 |
| Scheenen, W | 1 |
3 other studies available for nimodipine and Epilepsy, Absence
| Article | Year |
|---|---|
Role of L-type calcium channel modulation in nonconvulsive epilepsy in rats.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1995 |
The effects of chronic treatment with a calcium channel antagonist on two types of generalized epilepsies in rats.
Topics: Animals; Calcium Channel Blockers; Diet; Electroencephalography; Epilepsy, Absence; Epilepsy, Genera | 1994 |
Opposite effects of T- and L-type Ca(2+) channels blockers in generalized absence epilepsy.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 2000 |